Angiotensins
New findings in angiotensins described by H. Argani and co-researchers
Published in Blood Weekly, April 3rd, 2008
"As renin-angiotensin system (RAS) activity may affect the severity of oxidative stress and inflammatory markers, we assessed the effects of enalapril (E) and/or losartan (L) on these markers in renal transplant recipients with RAS polymorphisms. After determination by PCR of RAS genotypes, consisting of the angiotensin-converting enzymes (ACE I/D), angiotensinogens (AGT M235T) and angiotensin II type 1 receptors (ATR1 A1166C), 76 recipients were recruited randomly and assigned 4 groups," scientists in Iran report.
"The first (n = 17) and second (n = 24) groups were treated with E (E+: 10 mg/d) and L (L+: 50 mg/d) alone, respectively. The third positive control group (n...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-04-03)
More Articles from Blood Weekly
- Acute Promyelocytic Leukemia
Studies conducted at Y. Morimatsu et al on acute promyelocytic leukemia recently published - Aging
Research results from University of California update understanding of aging - Angiotensins
Studies from J. Villar and colleagues yield new information about angiotensins - Anti-Infectives
New anti-infectives research from University of Bonn outlined - Antifungals
Study findings on antifungals are outlined in reports from University of Iowa, Medical Department - Bariatrics
Reports summarize bariatrics study results from N. Kermarrec and co-researchers - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
